Weekly Analysts’ Ratings Changes for UnitedHealth Group (UNH)

A number of firms have modified their ratings and price targets on shares of UnitedHealth Group (NYSE: UNH) recently:

• 10/24/2024 – UnitedHealth Group was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
• 10/22/2024 – UnitedHealth Group had its price target lowered by analysts at Barclays PLC from $604.00 to $603.00. They now have an “overweight” rating on the stock.
• 10/18/2024 – UnitedHealth Group had its price target raised by analysts at TD Cowen from $601.00 to $609.00. They now have a “buy” rating on the stock.
• 10/17/2024 – UnitedHealth Group was downgraded by analysts at Hsbc Global Res from a “strong-buy” rating to a “hold” rating.
• 10/17/2024 – UnitedHealth Group was downgraded by analysts at HSBC Holdings plc from a “buy” rating to a “hold” rating.
• 10/16/2024 – UnitedHealth Group had its price target raised by analysts at Cantor Fitzgerald from $591.00 to $644.00. They now have an “overweight” rating on the stock.
• 10/16/2024 – UnitedHealth Group had its price target lowered by analysts at Stephens from $632.00 to $605.00. They now have an “overweight” rating on the stock.
• 10/16/2024 – UnitedHealth Group had its price target lowered by analysts at Morgan Stanley from $615.00 to $610.00. They now have an “overweight” rating on the stock.
• 10/16/2024 – UnitedHealth Group had its price target lowered by analysts at Royal Bank of Canada from $615.00 to $595.00. They now have an “outperform” rating on the stock.
• 10/16/2024 – UnitedHealth Group was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 10/16/2024 – UnitedHealth Group had its price target lowered by analysts at UBS Group AG from $680.00 to $650.00. They now have a “buy” rating on the stock.
• 10/16/2024 – UnitedHealth Group had its “buy” rating reaffirmed by analysts at Truist Financial Co.. They now have a $625.00 price target on the stock, down previously from $640.00.
• 10/16/2024 – UnitedHealth Group had its price target lowered by analysts at Bank of America Co. from $675.00 to $650.00. They now have a “buy” rating on the stock.
• 10/11/2024 – UnitedHealth Group is now covered by analysts at KeyCorp. They set an “overweight” rating and a $675.00 price target on the stock.
• 10/10/2024 – UnitedHealth Group was upgraded by analysts at KeyCorp to a “strong-buy” rating.
• 10/1/2024 – UnitedHealth Group had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $591.00 price target on the stock.
• 9/25/2024 – UnitedHealth Group was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
• 9/17/2024 – UnitedHealth Group was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 9/16/2024 – UnitedHealth Group had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $591.00 price target on the stock.
• 9/10/2024 – UnitedHealth Group had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $591.00 price target on the stock.
• 9/9/2024 – UnitedHealth Group was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $557.77 on Tuesday. The company has a market cap of $515.05 billion, a PE ratio of 36.34, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. The company has a 50-day simple moving average of $581.37 and a 200-day simple moving average of $542.90.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $6.56 EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.51%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Institutional Investors Weigh In On UnitedHealth Group

Hedge funds and other institutional investors have recently made changes to their positions in the stock. China Universal Asset Management Co. Ltd. boosted its position in shares of UnitedHealth Group by 20.6% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock valued at $5,376,000 after acquiring an additional 1,857 shares during the last quarter. Quent Capital LLC grew its stake in UnitedHealth Group by 5.5% in the first quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock worth $2,076,000 after purchasing an additional 217 shares during the period. Avidian Wealth Solutions LLC grew its stake in shares of UnitedHealth Group by 31.3% in the first quarter. Avidian Wealth Solutions LLC now owns 2,394 shares of the healthcare conglomerate’s stock worth $1,184,000 after acquiring an additional 571 shares during the last quarter. Embree Financial Group lifted its position in UnitedHealth Group by 12.1% in the 1st quarter. Embree Financial Group now owns 613 shares of the healthcare conglomerate’s stock valued at $303,000 after acquiring an additional 66 shares in the last quarter. Finally, Richardson Financial Services Inc. raised its holdings in UnitedHealth Group by 10.4% in the 1st quarter. Richardson Financial Services Inc. now owns 2,605 shares of the healthcare conglomerate’s stock worth $1,289,000 after purchasing an additional 246 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.